SMS Pharmaceuticals has received an approval for appointment of an Independent Committee to explore the possibilities of demerger of Non-FDA Manufacturing Units of the company. The board of directors at their meeting held on February 06, 2015 have approved for the same.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. The company is diversifying into CRAMS by creating research and manufacturing facilities bettering the requirements of the regulatory markets to appeal to international clientele.
